Follow-up study of expression of Bcl-2, Bax, p53 and ACE in CD34+ cells of peripheral blood and bone marrow in acute leukemia patients in the course of induction chemotherapy
- 作者: Khodunova E.E.1, Parovichnikova E.N.1, Gal'tseva I.V.1, Kulikov S.M.1, Isaev V.G.1, Savchenko V.G.1, Khodunova EE2, Parovichnikova EN2, Galtseva IV2, Kulikov SM2, Isaev VG2, Savchenko VG2
-
隶属关系:
- Hematological Research Center, Moscow
- 期: 卷 83, 编号 7 (2011)
- 页面: 32-37
- 栏目: Editorial
- ##submission.dateSubmitted##: 10.04.2020
- ##submission.datePublished##: 15.07.2011
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30870
- ID: 30870
如何引用文章
全文:
详细
Material and methods. Flow cytoflowmetry estimated expression of Bcl-2, Bax, p53 and ACE in the cells CD34+ of BM and PB from 10 AL (4 AML and 6 ALL) patients. PB and BM samples were studied before polychemotherapy (PCT) and in the course of induction treatment: on day +8, +21 (blood only), +36 - 38. Control group consisted of 4 BM donors.
Results. The number of CD34+ cells expressing Bcl-2 in AL patients was 46,5 ± 9,35 % in BM and 39,4 + 10,8 % in PB, in healthy donors - 9 and 32,8 %, respectively. Bax expression in AL patients' cells CD34+ of BM versus this expression in donors was 3 times higher (36,7 ± 8,1 and 14,8%, respectively), of PC - 2 times lower (40,7 ± 6,59 and 75,8%, respectively). Expression of p53 in AL patients was 36,8 ± 9 % in BM and 26 ± 7,4 % in PB, in donors - 28,2 and 65 %, respectively. ACE expression on the cells CD34+ in AL patients in early disease was 62 ± 7,57 % in BM and 48 ± 8,1 % in PB, in donors - 40 and 85 %, respectively. Moreover, there were significant changes in expression of Bcl-2 in BM and Bax, ACE and p53 in PB in the cells CD34+ in AL patients during and after induction PCT.
Conclusion. The above changes evidence for unbalance of pro- and antiapoptosis proteins of regulators in AL patients. PCT changes profile of expression of these proteins, but not to the level of healthy donors.
作者简介
Elena Khodunova
Email: Hodunova_Lena@mail.ru
Elena Parovichnikova
Email: elenap@blood.ru
Irina Gal'tseva
Sergey Kulikov
Valentin Isaev
Valeriy Savchenko
E Khodunova
Hematological Research Center, MoscowHematological Research Center, Moscow
E Parovichnikova
Hematological Research Center, MoscowHematological Research Center, Moscow
I Galtseva
Hematological Research Center, MoscowHematological Research Center, Moscow
S Kulikov
Hematological Research Center, MoscowHematological Research Center, Moscow
V Isaev
Hematological Research Center, MoscowHematological Research Center, Moscow
V Savchenko
Hematological Research Center, MoscowHematological Research Center, Moscow
参考
- Волкова М. А. (ред.). Клиническая онкогематология: Руководство для врачей. М.: Медицина; 2001.
- Савченко В. Г., Паровичникова Е. Н. Лечение острых лейкозов. М. : МЕДпресс-информ; 2004.
- Testa U., Riccioni R. Deregulation of apoptosis in acute myeloid leukemia. Haematologica 2007; 92(1): 81-94.
- Li J., Volkov L. et al. Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells. Exp. Hematol. 1997; 25: 140-146.
- Poeta G. D., Venditti A. et al. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003; 101(6): 2125-2131.
- Marcucci G., Stock W. et al. Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: Pharmacokinetics, pharmacodynamics, and clinical activity. J. Clin. Oncol. 2005; 23(15): 3404- 3411.
- Aksu S., Beyazit Y. et al. Over-expression of angiotensin-converting enzyme (CD143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leukemia and Lymphoma 2006; 47(5): 891-896.
- Cavalcanti G. B. Jr., da Cunha Vasconcelos F., Pinto de Faria G. et al. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia. Cytometry B: Clin. Cytom. 2004; 61(1): 1-8.
- Antonsson B., Martinou J. C. The Bcl-2 protein family. Exp. Cell Res. 2000; 256(1): 50-57.
- Campos L., Rouault J. P., Sabido O. et al. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091- 3096.
- Levine J. L. et al. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
- Ladich H. et al. Molecular cell biology. Scientific American books. New Jork, l995.
- Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-1449.
- Kaufmann S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 1989; 49: 5870-5878.
- Van Stijn A., Van Der Pol M. A., Kok А. et al. Differences between the CD34+ and CD34-blast compartments in apoptosis resistance in acute myeloid leukemia. Hematological 2003; 88: 497-508.
- Seliger B., Papadileris S., Vogel D. et al. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia. Eur. J. Hematol. 1996; 57: 230-240.
- Gump J., Mcgavran L., Wei Q., Hunger S. P. Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 2001; 23: 416-425.
- Jokubaitis V., Sinka L. et al. Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 2008; 111: 4055- 4063.
- Inigo S. D., Lopez-Jorge C. E., Gomez-Casares M. T. et al. Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents. Leukemia Res. 2009; 33: 810-816.
- Beyazit Y., Aksu S., Haznedaroglu I. C. et al. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. J. Natl Med. Assoc. 2007; 99: 57-63.
- Herr I., Debatin K. M. Cellular stress response and apoptosis in cancer therapy. Blood 2001; 98(9): 2603-2614.
- Konopleva M., Tari A. M. et al. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. Blood 2000; 95: 3929-3938.
- Haznedaroglu I. C., Beyazit Y. Pathobiological aspects of the local bone marrow renin-angiotensin system: a review. Renin-Angiotensin-Aldosterone Syst. 2010; 11(4): 205-213.
- Aksu S., Beyazit Y., Haznedaroglu I. C. et al. Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia Rubra vera. J. Int. Med. Res. 2005; 33: 661-667.
- Srinivas G., Nair N. K., Panicker K. R., Pillai M. R. Mutant p53, Bcl-2/Bax ratios and apoptosis in pediatric acute lymphoblastic leukemia. J. Cancer Res. Clin. Oncol. 2000; 126: 62-67.
- Hadir A., Nayera H. et al. The expression of Bcl-2 and Bax Proteins and their clinical relevance in ALL and CLL patients. J. Egypt. Natl. Cancer Inst. 2001; 13(1): 35-42.
补充文件
![](/img/style/loading.gif)